The FDA has granted Glenmark Pharmaceuticals approval for its Rizatriptan Benzoate orally disintegrating tablets in the 5- and 10-milligram strengths to address migraine. The drug is a generic version of Merck's Maxalt MLT tablets.
The FDA approved Glenmark Generics' anti-epileptic drug lamotrigine. The treatment is a generic version of GlaxoSmithKline's Lamictal. Glenmark's product will be available in 200-, 150-, 100- and 25-milligram tablets.
The FDA granted Glenmark Generics marketing approval for extended-release verapamil in 120- and 180-milligram doses. Glenmark already sells a 240-milligram dose of the product, a generic version of Ranbaxy Laboratories' hypertension drug Isoptin SR.